The India Decade

Health

CSIR-CCMB scientists discover new drug targets to tackle Tuberculosis

Scientists have mapped the protein export machinery of the Tuberculosis pathogen, opening fresh avenues to develop drugs against resistant strains.

Researchers at the CSIR-Centre for Cellular and Molecular Biology have identified critical vulnerabilities in the Tuberculosis bacterium by mapping its protein export network. The landmark findings demonstrate India's expanding scientific capabilities in tackling major public health challenges.

More in Health